DPTX3186

· Dewpoint Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DPTX3186, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: DPTX3186 in Wnt Pathway Activated Solid Tumors [Phase 1]